PetVivo Holdings Hits New 52-Week High of $0.66, Up 65.48%

PetVivo Holdings, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a 52-week high of $0.66 on September 22, 2025. This achievement marks a notable increase from its 52-week low of $0.40, reflecting a robust performance over the past year.
In the last 12 months, PetVivo Holdings has demonstrated a remarkable growth rate of 65.48%, significantly outperforming the S&P 500, which recorded a gain of 16.64% during the same period. Despite being a loss-making entity, the company operates within an industry that is often characterized by high volatility and potential for innovation.

With a market capitalization of approximately $23 million, PetVivo Holdings is positioned within the microcap segment, which typically involves higher risk but also the possibility for substantial returns. The company's financial metrics, including a price-to-book ratio of 6.16 and a negative return on equity of -222.52%, indicate the challenges it faces in achieving profitability. As PetVivo Holdings continues to navigate the complexities of the biotechnology landscape, its recent price movement underscores the dynamic nature of the market.